11th May is close to 60 days from conference call.
I am wondering if RAP management have a FDA meeting date as yet.
If RAP does have an FDA meeting date , it would be most appreciated and courteous to inform shareholders. We are all in this together.
I sincerely hope that RAP management see commonsense wisdom in having assoc Prof Abeyratne present during this up coming FDA meeting.
Zoom, zoom, zoom...
Stay safe
MB
Ann: Investor Conference Call, page-215
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #